Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIM-DRS in Pseudophakic Patients With Mild to Moderate OAG or OHT
NCT07641296Phase 1Not yet recruiting
- Start
- Jul 2026
- Primary completion
- Feb 2027
01
Overview
Phase 1, open-label trial of bimatoprost in open-angle glaucoma (OAG) and ocular hypertension (4 arms). Primary endpoint: Mean Intraocular Pressure change from Baseline at Month 3. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT07641296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07641296.